Shanghai, Sept 3, 2026 — Shanghai’s Medical Procurement Center said it will revoke procurement qualifications for certain selected traditional Chinese medicine (TCM) herb slices starting Sept 5, 2026, following a national alliance decision to disqualify individual enterprises for violations and place them on a non-compliance list.
Policy Snapshot
| Attribute | Detail |
|---|---|
| Issuer | Shanghai Medical Centralized Bidding and Procurement Affairs Management Center |
| Document | Notice on the Revocation of Qualification for Procuring Certain Selected Traditional Chinese Medicine Herbs |
| Effective date | Sept 5, 2026 |
| Legal basis | National TCM Decoction Pieces Alliance Procurement Office announcement on canceling selected enterprise qualifications and listing violators |
| Scope | Selected TCM herb slices (decoction pieces) under the national alliance procurement program |
| Affected parties | Medical institutions with contracted purchase volumes for the disqualified varieties |
Key Provisions
- Qualification revocation — Starting Sept 5, the selected procurement status of the relevant TCM herb slices is canceled. Medical institutions must update their systems and complete invoice verification accordingly.
- Volume fulfillment mechanism — Hospitals with contracted purchase volumes for the disqualified varieties may procure alternative selected products to fulfill their contracted obligations, with such purchases counted toward completion of the original volume commitments.
- Compliance enforcement — The action aligns with the national TCM decoction pieces alliance’s penalty decision against enterprises found in violation of procurement rules.
Market Impact Analysis
The disqualification immediately removes one or more suppliers from Shanghai’s TCM herb procurement channel, forcing medical institutions to redirect orders to remaining qualified manufacturers within the national alliance catalog. For hospitals with active contracts for the affected varieties, the alternative procurement provision prevents supply disruptions while ensuring volume targets are met, though switching suppliers may involve re-qualification of product specifications and potential price adjustments.
For the broader TCM decoction pieces market, the enforcement action signals that the national alliance procurement regime—which has historically faced challenges with quality consistency and supply reliability—is actively penalizing non-compliant participants. This may strengthen the bargaining position of compliant suppliers and accelerate consolidation among smaller herb processors unable to meet alliance standards.
Forward-Looking Statement
Industry analysts expect the national TCM decoction pieces alliance to publish additional disqualification notices across other member provinces in the coming weeks, as the coordinated procurement framework applies penalties uniformly. Medical institutions in Shanghai should complete system updates and supplier transitions by the Sept 5 deadline to avoid procurement compliance gaps. The volume fulfillment flexibility—allowing alternative selected products to count toward original commitments—suggests regulators are prioritizing supply continuity over rigid contractual adherence, a pragmatic approach that may be replicated in future enforcement actions. Companies remaining on the qualified supplier list are positioned to capture redirected volume, potentially boosting market share in the fragmented TCM herb slices segment.-China Health Reform Pulse
Policy Source: https://www.smpaa.cn/xxgk/gggs/2026/09/03/24299.shtml